Cancer Clinical Trial -Peel Therapeutics-PEEL-224-001

Cancer

Status:

NCT03260894/NCT's differ

ClinicalTrials.gov:

NCT05329103

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

Drug

PEEL-224

Phase

Phase I

Condition

Advanced Malignancies

Keywords

TOP 1 Inhibitor